• To manage complex diseases more simply.

Competent Partner, Strong Service Provider, Reliable Manufacturer

Patient-specific medicinal products are becoming increasingly important. As an innovative specialty pharmaceuticals company, Medios focuses on integrated solutions and partnership intelligence to ensure optimal supply. 



Medios AG: Deutsche Bank initiates coverage on Medios with a 'Buy' recommendation and a price target of €50.00


Think about tomorrow

From the very beginning, responsible action and management at Medios has included the aspect of sustainability.

Reporting Center

Reporting fiscal year 2020

More on this in the Reporting Center

Thinking Holistically About Specialty Pharma — Achieving the Best Together

Our holistic approach makes Medios one of the leading providers of individualized medicinal products. As a competence partner for specialized pharmacies and medical specialists, we cover a large part of the supply chain and develop comprehensive solutions for the specialty pharma division. 

Supply of Medicinal Products
Special Medication and More

In addition to the reliable supply of patient-specific therapies and finished medicinal products, we support specialized pharmacies with a wide range of services, including intelligent services and the open Medios network.

Patient-Specific Therapies — Made by Medios

As a pharmaceutical manufacturer according to Section 13 AMG (German Medicines Act), we prepare patient-specific drugs in accordance with the strictest GMP guidelines.

Investor Relations
Everything for Investors

Since our IPO, Medios has become a first mover in the demanding specialty pharmaceuticals market segment and is on a steady path to success.

From Internship to Professional

Engaging tasks, bright prospects for the future, great teamwork — Medios offers experienced professionals as well as newly qualified individuals a wide range of career opportunities.

Partner Network

Combined Expertise in the Medios Partner Network

Medios offers pharmacies and specialist physicians an open partner network for specialty pharmaceuticals that benefits everyone.


Play it safe

Since 01.09.2020, the legislation for more safety in the supply of pharmaceutical drugs (GSAV), has allowed for the supply of Hemophilia preparations to patients through public pharmacies. Medios offers pharmacies a comprehensive range of services in this indication area – consisting of nationwide emergency depots, around-the-clock availability and competent advice on all questions concerning the supply of hemophilia preparations.



Medios AG: Deutsche Bank initiates coverage on Medios with a 'Buy'...